SARS-COV-2 Viral Budding and Entry can be Modeled Using BSL-2 Level Virus-Like Particles

被引：0
|
作者：
Plescia, Caroline
David, Emily
Patra, Dhabaleswar
Sengupta, Ranjan
Amiar, Souad
Su, Yuan
Stahelin, Robert
机构：
来源：
FASEB JOURNAL | 2021年 / 35卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1096/fasebj.2021.35.S1.03012
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
    Elfayres, Ghada
    Paswan, Ricky Raj
    Sika, Laura
    Girard, Marie-Pierre
    Khalfi, Soumia
    Letanneur, Claire
    Milette, Keziah
    Singh, Amita
    Kobinger, Gary
    Berthoux, Lionel
    JOURNAL OF VIROLOGICAL METHODS, 2023, 322
  • [22] Kinetic Landscape of Single Virus-like Particles Highlights the Efficacy of SARS-CoV-2 Internalization
    Atemin, Aleksandar
    Ivanova, Aneliya
    Peppel, Wiley
    Stamatov, Rumen
    Gallegos, Rodrigo
    Durden, Haley
    Uzunova, Sonya
    Vershinin, Michael D.
    Saffarian, Saveez
    Stoynov, Stoyno S.
    VIRUSES-BASEL, 2024, 16 (08):
  • [23] A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation
    Chen, Zinuo
    Cui, Qinghua
    Ran, Yan
    Achi, Jazmin Galvan
    Chen, Zhaoyu
    Rong, Lijun
    Du, Ruikun
    JOURNAL OF VIROLOGY, 2024, 98 (07)
  • [24] Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles
    Kumar, Binod
    Hawkins, Grant M.
    Kicmal, Tom
    Qing, Enya
    Timm, Emily
    Gallagher, Tom
    CELLS, 2021, 10 (04)
  • [25] Strengths and limitations of SARS-CoV-2 virus-like particle systems
    Sultana, Rokaia
    Stahelin, Robert V.
    VIROLOGY, 2025, 601
  • [26] S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern
    Heo, Chang-Kyu
    Lim, Won-Hee
    Moon, Ki-Beom
    Yang, Jihyun
    Kim, Sang Jick
    Kim, Hyun-Soon
    Kim, Doo-Jin
    Cho, Eun-Wie
    VACCINES, 2024, 12 (06)
  • [27] A cell based assay using virus-like particles to screen AM type mimics for SARS-CoV-2 neutralisation
    Gaur, Neeraj Kailash
    Urankar, Shreegauri
    Sengupta, Durba
    Chepuri, V. Ramana
    Makde, Ravindra D.
    Kulkarni, Kiran
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 718
  • [28] Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles
    Syed, Abdullah M.
    Taha, Taha Y.
    Tabata, Takako
    Chen, Irene P.
    Ciling, Alison
    Khalid, Mir M.
    Sreekumar, Bharath
    Chen, Pei-Yi
    Hayashi, Jennifer M.
    Soczek, Katarzyna M.
    Ott, Melanie
    Doudna, Jennifer A.
    SCIENCE, 2021, 374 (6575) : 1626 - +
  • [29] Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
    Syed, Abdullah M.
    Ciling, Alison
    Taha, Y. Taha
    Chen, Irene P.
    Khalid, Mir M.
    Sreekumar, Bharath
    Chen, Pei-Yi
    Kumar, G. Renuka
    Suryawanshi, Rahul
    Silva, Ines
    Milbes, Bilal
    Kojima, Noah
    Hess, Victoria
    Shacreaw, Maria
    Lopez, Lauren
    Brobeck, Matthew
    Turner, Fred
    Spraggon, Lee
    Tabata, Takako
    Ott, Melanie
    Doudna, Jennifer A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (31)
  • [30] ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
    Hoffmann, Magnus A. G.
    Yang, Zhi
    Huey-Tubman, Kathryn E.
    Cohen, Alexander A.
    Gnanapragasam, Priyanthi N. P.
    Nakatomi, Leesa M.
    Storm, Kaya N.
    Moon, Woohyun J.
    Lin, Paulo J. C.
    West Jr, Anthony P.
    Bjorkman, Pamela J.
    CELL, 2023, 186 (11) : 2380 - +
12345